# Specialty Drugs

Type: Product

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/specialty-drugs
Canonical HTML page: https://getfinancebrief.com/entity/specialty-drugs

## Recent coverage (1 stories)

### US tariff split: 0% on 20 countries' specialty drugs, 100% on rest
2026-09-30 19:39:03 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

The US Commerce Department's zero ad valorem tariff for specialty pharmaceuticals from 20 countries, including India, creates a two-tier import regime alongside a 100% tariff on other patented medicines. Investors should assess exposure for biopharma, logistics, and healthcare companies in exempt versus non-exempt markets.
Full story: https://getfinancebrief.com/story/finance-us-specialty-pharma-tariff-split-20-countries

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.